Powered by

-Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

Jul 28, 2020 - ENP Newswire

Holzkirchen - Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.

Sandoz CEO Richard Saynor said: 'This plan is a great example of government and the private sector working closely together to protect the long-term interests of patients in Europe and beyond. Antibiotics are the backbone of modern medici...